[1]
Ebrahimi, E. and Shirkoohi, R. 2018. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer. (Nov. 2018), 148-149. DOI:https://doi.org/10.32768/abc.201854148-149.